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Abstract
Birt-Hogg-Dube (BHD) is a tumor suppressor gene syndrome associated with fibrofolliculomas, cystic lung disease, and
chromophobe renal cell carcinoma. In seeking to elucidate the pathogenesis of BHD, we discovered a physical interaction
between folliculin (FLCN), the protein product of the BHD gene, and p0071, an armadillo repeat containing protein that
localizes to the cytoplasm and to adherens junctions. Adherens junctions are one of the three cell-cell junctions that are
essential to the establishment and maintenance of the cellular architecture of all epithelial tissues. Surprisingly, we found
that downregulation of FLCN leads to increased cell-cell adhesion in functional cell-based assays and disruption of cell
polarity in a three-dimensional lumen-forming assay, both of which are phenocopied by downregulation of p0071. These
data indicate that the FLCN-p0071 protein complex is a negative regulator of cell-cell adhesion. We also found that FLCN
positively regulates RhoA activity and Rho-associated kinase activity, consistent with the only known function of p0071.
Finally, to examine the role of Flcn loss on cell-cell adhesion in vivo, we utilized keratin-14 cre-recombinase (K14-cre) to
inactivate Flcn in the mouse epidermis. The K14-Cre-Bhd
flox/flox mice have striking delays in eyelid opening, wavy fur, hair
loss, and epidermal hyperplasia with increased levels of mammalian target of rapamycin complex 1 (mTORC1) activity.
These data support a model in which dysregulation of the FLCN-p0071 interaction leads to alterations in cell adhesion, cell
polarity, and RhoA signaling, with broad implications for the role of cell-cell adhesion molecules in the pathogenesis of
human disease, including emphysema and renal cell carcinoma.
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Introduction
Cell-cell junctions, which include adherens junctions, desmo-
somes, and tight junctions, are fundamental to the intricate cellular
architecture of all epithelial tissues [1]. Because cell-cell junctions
allow the epithelium to function as a coordinated tissue, they must
be dynamically regulated and remodeled during growth and
development, in response to injury, and during normal tissue
homeostasis. Adherens junctions link neighboring epithelial cells to
the actin cytoskeleton, and desmosomes link them to keratin
intermediate filaments. Adherens junctions classically contain E-
cadherin and p120-catenin while desmosomes contain desmosom-
al cadherins and plakophilins. In addition to their structural roles,
cell-cell junctions play key roles in cell signaling and are
increasingly recognized to participate in cancer pathogenesis
[2,3,4,5,6,7,8].
In seeking to elucidate the functions of folliculin (FLCN), the
protein product of the Birt-Hogg-Dube (BHD) gene, we used
a yeast two-hybrid approach to uncover a physical interaction
between the junctional protein p0071 (also called plakophilin 4)
and FLCN. p0071 is a relatively understudied member of the
armadillo repeat-containing protein family, which includes p120-
catenin (p0071’s closest homolog) and beta-catenin [9]. Both
p120-catenin and p0071 are components of adherens junctions,
and both also localize to the cytoplasm where they regulate the
small GTPase RhoA [10]. However, p0071 acts as a positive
regulator of RhoA, while p120-catenin is a negative regulator
[11,12].
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e47842FLCN is a 64 kDa highly conserved protein with no obvious
functional domains. Germline mutations of the BHD gene, which
is on chromosome 17p11.2 and was cloned in 2002 [13], lead to
an autosomal dominant disease associated with fibrofolliculomas
(benign skin tumors), cystic lung disease, which can result in
spontaneous pneumothorax (lung collapse), and renal cell carci-
nomas (RCC), which are most often of the chromophobe subtype.
The penetrance of these phenotypes is incomplete: 15–30% of
BHD patients develop RCC [14], and families have been reported
in which cystic lung disease and pneumothorax occur in the
absence of renal or skin manifestations [15,16,17,18]. Nearly all
germline BHD mutations are truncating, and RCC from BHD
patients exhibit loss of heterozygosity of chromosome 17p
[14,19,20], consistent with the hypothesis that BHD is a tumor
suppressor gene.
FLCN is known to exist in a complex with AMP-associated
protein kinase (AMPK) via two interacting proteins: Folliculin-
interacting protein 1 (FNIP1) and FNIP2 [21,22,23]. FLCN-
deficient cells have dysregulated signaling through AMP-associat-
ed protein kinase (AMPK), mammalian target of Rapamycin
complex 1 (mTORC1), hypoxia inducible factor (HIF), and
transforming growth factor-b (TGF-b)
[21,22,23,24,25,26,27,28,29,30]. Despite these advances, the
molecular functions of FLCN and the cellular mechanisms
through which BHD mutations lead to renal and skin tumorigen-
esis and cystic lung disease are incompletely understood.
We found that downregulation of either FLCN or p0071 results
in increased cell-cell adhesion, which is surprising given the
conventional view that decreased cell-cell adhesion is associated
with tumorigenesis. These results implicate enhanced cell-cell
adhesion as a contributing factor in tumorigenesis. To examine
this in vivo, we utilized a classic model of cell-cell adhesion
integrity: keratin-14 cre-recombinase (K14-cre) [31,32,33], which
is expressed in the epidermal layer of the skin. K14-Cre-Bhd
flox/
flox mice have delayed eyelid opening, wavy fur, hair loss, and
epidermal hyperplasia, phenotypes that resemble inactivation of
other cell adhesion proteins, including p120-catenin, using the
same promoter [34]. Together, our data support a model in which
FLCN is a guardian of epithelial integrity via its interaction with
p0071. Dysregulation of the FLCN-p0071 interaction may
underlie the unusual triad of lung, skin, and renal manifestations
in BHD patients, and could have critical implications for the
pathogenesis of cystic lung disease and chromophobe renal cell
carcinoma in the general population.
Results
p0071 Interacts with FLCN in Mammalian Cells
To elucidate the molecular functions of FLCN, we used a yeast
two-hybrid approach to discover novel FLCN interacting partners.
Full-length myc-FLCN was used as bait and screened against
a human fetal brain protein library (see Methods). The top hit was
p0071 (also called PKP4), which regulates Rho activity [10] and
localizes to cell-cell junctions (Figures 1A–B). Forty one different
prey regions of p0071 interacted with FLCN. Further analysis
suggested a minimum interaction domain between amino acids
472–774 of p0071 (Figure 1C).
To confirm that FLCN and p0071 interact, we performed
a GST-pulldown assay in which Madine-Darby canine kidney
(MDCK) cell lysates were incubated with either GST-FLCN, or
empty GST. p0071 interacts with GST-FLCN, but not GST
(Figure 1D). Next, we co-expressed myc-FLCN and FLAG-
p0071 in HEK293 cells and performed a myc immunoprecipita-
tion. As shown in Figure 1E, FLAG-p0071 co-immunoprecipi-
tates with myc-FLCN. Finally, to determine whether FLCN and
p0071 interact at endogenous levels, we immunoprecipitated
p0071 or FLCN from HEK293 cells; Figure 1F shows that
FLCN and p0071 co-immunoprecipitate at endogenous levels.
Collectively, these results strongly support a physical interaction
between FLCN and p0071.
FLCN-deficiency Leads to Decreased Rho Activity in Sub-
confluent Cells and Defects in Cell Migration
p0071 is known to positively regulate RhoA activity through an
interaction with the Rho guanine nucleotide exchange factor, Ect2
[10]. Therefore, to determine whether FLCN-deficiency pheno-
copies this known function of p0071, we examined Rho-associated
kinase (ROCK) activity in FLCN-null UOK257 and FLCN re-
expressing UOK257-2 cells. ROCK activity was analyzed by
monitoring the phosphorylation status of the myosin-binding
subunit of myosin light chain, a downstream substrate of ROCK
[35].
The phosphorylation of MBS was decreased in FLCN-null
UOK257 cells compared to the FLCN-expressing UOK257-2
cells (Figure 2A: lanes 1-3 compared to lanes 5-7), suggesting that
FLCN positively regulates ROCK activity. Hydroxyfasudil (HF),
an inhibitor of ROCK, and Lysophosphatidic acid (LPA), an
activator of ROCK, were used as controls. To directly measure
RhoA activity we performed a Rho activation assay in 70%-
confluent cells. Lysates were incubated with a GST-fusion protein
of the Rhotekin-binding domain and active and total Rho levels
were analyzed by immunoblot. As shown in Figure 2B (top),
UOK257-2 cells had a 2.5-fold increase in active GTP-bound Rho
compared to UOK257 cells (Figure 2B bottom panel, p,0.05).
Finally, we performed a wound-healing assay in UOK257 and
UOK257-2 cells and in A549 cells stably expressing control or
FLCN shRNA, to determine whether FLCN-deficiency affects cell
migration. Both proper RhoA signaling and cell polarity are
required for wound closure in vitro. Consistent with the above
RhoA data, wound closure in FLCN-deficient UOK257 and A549
cells was delayed when compared to FLCN-expressing cells
(Figure 2C–D).
FLCN Negatively Regulates Cell-cell Adhesion and
Desmosome Formation
With our discovery that FLCN interacts with p0071 and the
known role of p0071 localization to cell-cell junctions, we
postulated that FLCN could play a role in cell-cell adhesion.
Therefore, we analyzed cell-cell adhesion in UOK257 cells. Cell
suspensions were plated as hanging drops on the lid of a tissue
culture plate and incubated for three days to form three-
dimensional cell clusters; a standard shearing method was then
used to disrupt the clusters (see Methods) and the cells were labeled
with Hoechst prior to counting. Post shearing, 50% of the FLCN-
null UOK257 cells were still observed in clusters of 6 or more cells,
while 30% were in groups of ten or more cells (Figure 3A); in
contrast, none of the FLCN-expressing UOK257-2 cells were
found in clusters of 6 or more cells (p,0.001). Furthermore, more
than 80% of the sheared FLCN-expressing cells were found as
single cells, compared to approximately 30% of the FLCN-null
cells (p,0.001). These results suggest that FLCN negatively
regulates cell-cell adhesion.
To examine the mechanisms by which FLCN regulates cell-cell
adhesion, we next performed electron microscopy on confluent
UOK257 (FLCN-null) and UOK257-2 (FLCN-expressing) cells to
determine the impact of FLCN-deficiency on cell junction
formation. As shown in Figure 3B–E, FLCN-expressing
FLCN Interacts with p0071
PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e47842UOK257-2 cells (D–E) do not form desmosomes; however,
FLCN-null UOK257 cells (B–C) do. Interestingly, the FLCN-null
cells form both morphologically normal (3B) and abnormal (3C)
desmosomes. This data suggests that FLCN negatively regulates
desmosome formation, and is of particular interest given that renal
carcinomas have increased desmosomes compared to normal
kidney tissue [36].
To confirm that the hanging drop results were FLCN-
dependent and not cell-type specific to the UOK cells, we grew
T84 colon carcinoma cells stably expressing non-targeting or
FLCN shRNA in adherence-free conditions using a rotary shaker.
T84 cells were chosen because they are often used as an
experimental model for studies of cellular junctions [37]. In this
assay, cell survival is dependent on the ability of the cells to form
clusters. As shown in Figure 3F, the FLCN-deficient T84 cells
form larger clusters than the control cells. Together with the
hanging drop results, these data indicate that FLCN negatively
regulates cell-cell adhesion.
Figure 1. FLCN interacts with p0071. A) Schematic of the localization and known functions of p0071 and p120-catenin. B) The homology of
p0071 compared to the armadillo repeat proteins p120-catenin, the closest homolog of p0071, and beta-catenin. C) A representative structure of the
armadillo repeats of p0071 (AA 415–993). FLCN interacts with armadillo repeats 2–6 based on the yeast-two-hybrid data. D) p0071 interacts with GST-
FLCN. MDCK cell lysates were incubated with immobilized GST or GST-FLCN overnight. WCL – whole cell lysate input. E) myc-FLCN and FLAG-p0071
or myc-FLCN and FLAG-vector were expressed in HEK293 cells. Myc-FLCN was immunoprecipitated with anti-myc and detected with anti-FLCN.
p0071 was detected using anti-p0071 antibodies. IgG antibodies were used as a control (IgG). F) Endogenous p0071 immunoprecipitation (left) and
FLCN immunoprecipitation (right) in HEK293 cells showing co-immunoprecipitation of FLCN and p0071. IgG antibodies were used as a control (IgG).
doi:10.1371/journal.pone.0047842.g001
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PLOS ONE | www.plosone.org 4 November 2012 | Volume 7 | Issue 11 | e47842Figure 2. FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. A) Rho-associated kinase
(ROCK) activity was assayed by measuring the phosphorylation of myosin-binding subunit (MBS), a downstream substrate of ROCK. Cells were grown
in DMEM supplemented with 10% FBS (C), stimulated with Lysophosphatidic acid (LPA, 30 uM, 30 min), or treated with the ROCK inhibitor
Hydroxyfasudil (HF, 20 uM, 30 min). The phosphorylation of MBS was decreased in the FLCN-null UOK257 cells compared to the FLCN-expressing
UOK257-2 cells. FLCN levels were analyzed by western blot. B) Rho activity was measured using a Rhotekin binding assay at 70% confluence. The
FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n=3, p,0.05).
The data are expressed as mean 6 standard error by ANOVA. C) A wound assay was used to measure migration in UOK257 cells compared to
UOK257-2 cells. A scratch wound was administered (0 hr), and the wound size was measured at 8, 24, 48, 80, and 92 hr post wound induction. At 24
and 48 hours UOK257 cells had a larger wound area than UOK257-2 cells (n=3, p,0.05) indicating that the FLCN-null UOK257 cells migrate more
slowly than the FLCN re-expressing UOK257-2 cells. Data are expressed as mean 6 standard deviation. D) A scratch wound assay was performed as
described in (C) in A549 cells stably expressing FLCN shRNA or control shRNA. Images are shown at wound induction (0 hr), 48 hours post wound
induction (48 hr), and 90 hours post wound induction (90 hr). FLCN downregulation was monitored by western blot (bottom).
doi:10.1371/journal.pone.0047842.g002
Figure 3. FLCN influences p0071 protein expression, negatively regulates desmosome formation, and negatively regulates cell-cell
adhesion. A) The hanging drop assay (see Methods for details) was performed in UOK257 and UOK257-2 cells. After shearing, 60% of the FLCN-null
UOK257 cells were present in clusters of 6 or more cells. In contrast, none of the FLCN-expressing UOK257-2 cells remained in clusters of 6 or more
cells (n=3, p,0.001) and more than 80% sheared into single cells. (B–C) FLCN-null UOK257 cells and FLCN re-expressing UOK257-2 cells (D–E) were
grown to confluence and analyzed by electron microscopy (50,0006magnification). Desmosomes had normal (B) and abnormal (C) morphology. No
desmosomes were seen in the UOK257-2 cells; examples of cell-cell borders (marked by arrows) are shown (D–E). F) T84 (colon carcinoma-derived)
cells stably expressing either non-targeting (control) or FLCN shRNA were grown in adherence-free conditions (see Methods). FLCN shRNA cells form
large, spherical clusters suggesting increased cell-cell adhesion compared to non-targeting control shRNA cells. G–I) p0071, plakoglobin (JUP), ZO-1,
and p120 catenin levels were analyzed by western blot in UOK257 cells compared to UOK257-2 cells.
doi:10.1371/journal.pone.0047842.g003
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PLOS ONE | www.plosone.org 5 November 2012 | Volume 7 | Issue 11 | e47842FLCN Influences the Protein Levels of p0071, but not
Plakoglobin, ZO-1, or p120 Catenin
To determine whether FLCN is necessary for the expression of
cell junction proteins, we measured the levels of p0071,
plakoglobin (JUP), zonula occludens-1 (ZO-1), and p120 catenin
in UOK257 cells compared to UOK257-2 cells. JUP is
a desmosomal and adherens junction protein that forms complexes
with catenins and cadherins [38,39] and ZO-1 localizes to the cell
membrane at tight junctions [40,41]. p120 catenin is an adherens
junction protein that is known to regulate Rho activity [42,43] and
is the closest homolog of p0071.
As shown in Figures 3G–I, p0071 levels are decreased in
FLCN-null UOK257 cells, while JUP, ZO-1, and p120 catenin
levels are unaltered by FLCN-deficiency.
p0071 Loss Phenocopies FLCN-deficiency
To determine whether the increased cell-cell adhesion
observed in FLCN-deficient cells is mediated via the FLCN-
p0071 interaction, HEK293 cells that stably express non-
targeting, FLCN, or p0071 shRNA were grown in adherence-
free conditions as in 3F. After a standardized shearing protocol
(see Methods) the HEK293 cells expressing control shRNA
sheared into single cells or small clusters (Figure 4A top right
panel vs. top left panel). In contrast, the HEK293 cells
expressing FLCN shRNA remained in large clusters after
shearing (Figure 4A middle right panel vs. middle left panel).
Interestingly, in this assay, cells expressing p0071 shRNA also
formed large shear-resistant clusters (compare Figure 4A bottom
right and bottom left panels), similar to those formed by the
FLCN shRNA-expressing cells. Quantification of these findings
revealed that after shearing, 65% of the control cells formed
clusters of less than 10,000 pixels, whereas only 8% of the cells
that expressed FLCN shRNA (p,0.05) and only 12% of the
cells that express p0071 shRNA cells (p,0.05) formed clusters
of less than 10,000 pixels (Figure 4B). Downregulation of
FLCN and p0071 is shown in Figure 4C. These data suggest
that FLCN regulates cell-cell adhesion through its interaction
with p0071.
Keratins are the major structural component of intermediate
filaments in desmosomes, and play a critical role in cell-cell and
cell-matrix adhesion [44,45]. Our discovery that FLCN
negatively regulates desmosome formation (Fig 3B–E) led us
to hypothesize that keratin levels are affected by FLCN-
deficiency. To explore this, we performed pan-keratin immu-
nocytochemistry on UOK257 cells compared to UOK257-2
cells. As shown in Figure 4D, the keratin immunofluorescence
was stronger in UOK257 cells compared to UOK257-2 cells at
the same exposure. Interestingly, the keratin intermediate
filaments appear to be diffusely localized in the UOK257 and
UOK257-2 cells. Additionally, we analyzed keratin-18 immu-
nofluorescence via confocal microscopy. As shown in Figure 4E,
keratin-18 is more intense in UOK257 cells compared to
UOK257-2 cells. To verify that keratins are increased at the
protein level, we analyzed pan-keratin (Figure 4F) and keratin-
18 (Figure 4G) by western blot in the UOK cells. UOK257
cells displayed increased pan-keratin and keratin-18 protein
levels compared to UOK257-2 cells, indicating that FLCN-
deficiency leads to increased keratin levels consistent with our
finding that FLCN regulates desmosome formation. Down-
regulation of p0071 also led to increased levels of keratins
(Figure 4H) suggesting that keratin levels are mediated via the
FLCN-p0071 interaction.
p0071 and FLCN Impact Three Dimensional Lumen
Formation
The establishment of proper apical-basal polarity is another
important component of cellular homeostasis and defects in cell
polarity are commonly observed in tumorigenesis. Therefore, we
next examined the impact of FLCN and p0071 downregulation on
cell polarity. T84 cells stably expressing either non-targeting,
FLCN, or p0071 shRNA were grown in mixed extracellular
matrix proteins. These 3-dimensional matrices cause epithelial
cells to form spherical cysts consisting of a monolayer of epithelial
cells around a hollow lumen. The individual cells are connected to
each other by cell-cell contacts and form a highly polarized
structure where the apical surface is oriented to the lumen of the
cyst [46]. As shown in Figure 4I, downregulation of FLCN or
p0071 led to irregularly shaped and less organized cyst formation
with decreased lumen size. Taken together with our cell adhesion
data, these data suggest that deficiency of either FLCN or
p0071 leads to increased cell-cell adhesion and defects in cell
polarity.
Conditional Inactivation of Bhd in the Mouse Epidermis
Leads to Hair and Skin Abnormalities
Inactivation of junctional proteins with keratin-14 driven cre-
recombinase (K14-cre) is used frequently to study cell-cell
adhesion in vivo [31,32,33]. K14-cre is expressed in the skin
epithelium beginning at E13.5 [47,48]. We used K14-cre to
conditionally inactivate Bhd in the mouse skin, in order to evaluate
the effects of FLCN-deficiency on cell adhesion in vivo. Bhd
flox/flox
(Bhd
f/f) mice [49] were crossed with K14-cre mice to generate
Bhd
f/f K14-cre mice. By three weeks of age, the Bhd
f/f K14-cre
mice were significantly smaller than their littermate controls,
developed coarse and wavy hair, and displayed erythematous
patches of skin and hair loss, which progressed with age
(Figure 5A–B). In addition, 100% of the littermate wild type
control mice had opened their eyes by two weeks of age, but none
of the Bhd
f/f K14-cre mice had done so (representative image
shown in Figure 5C).
Further analysis of the Bhd
f/f K14-cre mouse skin revealed
a thickened epidermis involving the spinous layer (acanthosis),
granular layer (hypergranulosis) and stratum corneum (hyperker-
atosis) (Figure 6). In the epidermis, the distance from the basal
layer to the granular layer was 3-fold greater compared to
littermate controls (p,0.001), and displayed focal areas of
hyperkeratosis. Lastly, Bhd
f/f K14-cre mice display elevated levels
of phosphorylated ribosomal protein S6, an indicator of mTORC1
activity, in the hyperproliferative epidermis, suggesting that FLCN
negatively regulates mTORC1 in the skin.
Discussion
BHD is an autosomal dominant disease associated with lung
cysts, skin tumors, and kidney cancer, primarily of the chromo-
phobe subtype [50,51,52,53]. Germline BHD mutations also occur
in families with hereditary lung collapse (pneumothorax) without
renal or skin disease [15,16,17,18]. Somatic BHD mutations occur
in ,10% of sporadic chromophobe RCC [54]. We report here
that FLCN interacts with the adherens junction protein p0071 to
regulate cell-cell adhesion, cell migration, cell polarity, and RhoA
signaling. Furthermore, inactivation of FLCN in the basal layer of
the epidermis, which is classically used to study the in vivo impact
of cell adhesion proteins on the integrity of epithelial architecture,
results in striking phenotypes including wavy fur, epidermal
hyperplasia and inflammation, and defective eyelid opening.
FLCN Interacts with p0071
PLOS ONE | www.plosone.org 6 November 2012 | Volume 7 | Issue 11 | e47842Figure 4. p0071 loss phenocopies FLCN-deficiency. A) HEK293 cells expressing control non-targeting shRNA, FLCN shRNA, or p0071 shRNA
were cultured in anchorage-independent growth conditions using a rotary shaker and sheared (see Methods for details). A representative phase
contrast image is shown pre- and post-shear. B) Quantification of cell cluster size from (A) using pixel number. After shearing, 65% of the control cells
sheared into clusters of less than 10,000 pixels. In contrast, only 8% (n=3, p,0.01) of the FLCN shRNA cells and 12% (n=2, p,0.01) of the p0071
shRNA cells sheared into clusters of less than 10,000 pixels. Data in (A) and (C) are expressed as mean 6 standard deviation. C) Western blot analysis
of HEK293 cells showing decreased levels of p0071 using two different shRNAs (79, 80). Clone 80 was used in (A). D) UOK257 cells and UOK257-2 cells
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PLOS ONE | www.plosone.org 7 November 2012 | Volume 7 | Issue 11 | e47842These data provide a critical new component to our emerging
understanding of the pathogenesis of BHD. BHD is one of the
least studied monogenic tumor suppressor gene disorders, with
fewer than 12 publications on the functions of FLCN. FLCN has
been linked to AMPK signaling via a direct interaction with
FNIP1/2, to HIF signaling and mitochondrial dysfunction, to
aberrant TGF-beta signaling, and to mTOR complex 1 signaling
[21,22,23,25,29,49,55,56,57,58,59], but the fundamental mechan-
isms through which loss of FLCN leads to abnormalities in three
epithelial organs, the lung, the kidney, and the skin, remain
incompletely understood. Our data point toward a completely new
model in which regulation of the integrity of the epithelium via
cell-cell junctions is a critical function of FLCN.
Our finding that FLCN-deficient and p0071-deficient cells have
enhanced cell-cell adhesion is unexpected, given that cell-cell
junctions are critical for epithelial tissue homeostasis and loss of the
integrity of these junctions is associated with cancer progression
[2,5,7]. p120-catenin, the closest homolog of p0071, localizes to
adherens junctions and positively regulates cell adhesion in
prostate cancer-derived [60] and lung cancer-derived cells [61].
p0071 (also called PKP4) localizes to adherens junctions, but its
function in cell-cell adhesion has not been previously studied.
were analyzed by immunofluorescence using pan-keratin antibodies (206magnification). Pan-keratin immunofluorescence was stronger in FLCN-null
UOK257 cells. ZO-1 was used to identify cell borders. E) UOK257 cells and UOK257-2 cells were analyzed by immunofluorescence using keratin-18
antibodies (606magnification). Keratin 18 immunofluorescence was also stronger in FLCN-null UOK257 cells. F) pan-Keratin levels were compared by
immunoblot in UOK257 and UOK257-2 cells. Keratin levels were increased in the FLCN-null UOK257 cells. G) Keratin-18 levels were compared by
immunoblot in UOK257 and UOK257-2 cells. Keratin-18 levels were also increased in the FLCN-null UOK257 cells. H) Keratin levels were analyzed by
immunoblot in T84 cells expressing p0071 shRNA (+) or non-targeting control (-) shRNA. Keratin levels were elevated in p0071-deficient T84 cells. I)
FLCN and p0071 regulate lumen formation in a 3-dimensional matrigel assay. T84 cells stably expressing either non-targeting (control), FLCN, or
p0071 shRNA were stained for F-actin (red) and counter stained with DAPI (blue) to visualize nuclei. Downregulation of FLCN or p0071 leads to
disorganized, irregularly shaped cell clusters with smaller lumens. The bars represent 20 um.
doi:10.1371/journal.pone.0047842.g004
Figure 5. Bhd
f/f K14-Cre mice have wavy hair, erythematous skin, and delayed eyelid opening. A) Bhd
f/f K14-cre mice at three weeks of
age display coarse, wavy fur and wavy whiskers compared to Bhd
f/f wild-type mice. B) A representative Bhd
f/f K14-cre mouse at three weeks of age
with erythematous skin and hair loss (arrow). C) 100% of Bhd
f/f K14-cre mice have closed eyelids at three weeks of age (arrow) compared to 0% of
wild-type mice.
doi:10.1371/journal.pone.0047842.g005
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localization of p0071. We have observed desmosomal defects in
FLCN-deficient cells (Figure 3), but at this stage we cannot ascribe
the FLCN effects exclusively to one type of junction. Furthermore,
the effects of loss of FLCN or p0071 may result in part from the
impact on p0071’s other interacting partners, which include E-
cadherin [62], a critical component of adherens junctions.
Germline loss-of-function mutations in the CDH1 gene, which
encodes E-cadherin, cause human gastric cancer [3,4,6,8].
In addition to their localization to adherens junctions, both
p120-catenin and p0071 localize to the cytoplasm where they
regulate RhoA activity [10,11,12]. Our data that FLCN-deficient
cells have low levels of RhoA and ROCK activity are consistent
with the known role of p0071 as a positive regulator of RhoA, but
surprising given that RhoA is often activated in human cancer
[63,64,65]. The TGF-beta signaling network, which is often
activated in human cancer [66,67,68], is also downregulated in
FLCN-deficient cells, and mTORC1 signaling can be either up or
downregulated in FLCN-deficient cells depending on the cell type
and context [21,25,49,55,56]. Therefore the signaling conse-
quences of FLCN deficient cells do not appear to align precisely
with those of other tumors, or of other genetic diseases associated
with kidney cancer and skin tumors, such as tuberous sclerosis
complex [69,70,71]. Some of the signaling functions of FLCN for
which a molecular mechanism is not yet clearly identified,
including mTORC1 and TGF-beta, could be downstream of the
FLCN-p0071 interaction, either through a mechanism arising at
the cell-cell junction or via RhoA.
Patients with mutations in the BHD gene develop renal cell
carcinomas (RCC), the majority of which are chromophobe and
Figure 6. Bhd
f/f K14-Cre mice exhibit increased epidermal thickness. A) Bhd
f/f K14-cre mice exhibit acanthosis and hyperkeratosis (arrows)
compared to littermate control Bhd
f/f wild-type mice at three weeks of age. H&E stain, 206magnification. B) Skin region from (A) at 406magnification
with the epidermal layer outlined and vertical bars showing the thickness from the epidermal basement membrane to the granular layer. Scale bars
are 100 mm for both (A) and (B). C) Quantification of the thickness of the epidermis. The Bhd
f/f K14-cre mice have a 3-fold increase in thickness of the
epidermis (n=4, p,0.001). Data are expressed as mean 6 standard deviation. D) Bhd
f/f K14-cre mice exhibit elevated levels of phosphorylated
ribosomal protein S6 (S235/236, red staining), a readout or mTORC1 activity, compared to littermate control Bhd
f/f wild-type mice at three weeks of
age. 206magnification. E) A representative western blot of the skin of a 7 month old Bhd
f/f K14-cre mouse compared to the skin of a littermate
control at 7 months of age. beta-catenin, E-cadherin, p120 catenin, and phospho-NF-kB levels are increased in the mutant skin.
doi:10.1371/journal.pone.0047842.g006
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tions have been found in sporadic chromophobe RCC, which is
a rare disease affecting ,1500 individuals in the United States
each year. There appear to be at least two potential links between
defective cell junctions and sporadic RCC. First, we found that
FLCN-deficient cells have more desmosomes than FLCN-expres-
sing cells, and Kim et al. found that desmosomes are increased in
RCC compared to normal kidney tissue and identified an
association between desmosome number and tumor grade [36].
Second, Walter et al. found that p0071, which is expressed in
human and mouse kidney epithelium [7,72], appears to be lost in
41% of chromophobe RCC [7]; we found that p0071 interacts
with FLCN and that loss of p0071 phenocopies loss of FLCN in
cell-based assays. These fundamental mechanistic connections
between cell-cell junctions and the pathogenesis of sporadic
chromophobe RCC could eventually lead to an improved
understanding of disease pathogenesis and the development of
targeted strategies for metastatic chromophobe RCC, for which
there are currently no known effective therapies.
The cellular and physiologic mechanisms that lead to cystic and
emphysematous airspace enlargement in BHD are not known.
Respiration exposes the lung to unique mechanical forces. Cell-cell
junctions allow the lung to expand in response to these forces and
then ‘‘snap back’’ to their original shape and organization.
Mechanical-induced stretch of pulmonary alveolar type II cells
leads to widened cell-cell gaps and is speculated to be a protective
mechanism in response to lung injury, likely due to a flexibility
effect [73], and defects in tight junctions lead to lung injury and
fibrosis in mice [74]. We hypothesize that the defects in cell-cell
adhesion in FLCN-deficient cells underlie the pathogenesis of
airspace enlargement in BHD. If correct, this could lead to an
improved understanding of airspace enlargement in other diseases
including emphysema and chronic obstructive pulmonary disease
(COPD), the third leading cause of death in the world.
Finally, we have developed a novel mouse model in which Bhd is
inactivated in the epidermis via the Keratin-14 (K14) promoter.
K14-cre driven inactivation of adhesion proteins has been used to
study other junctional proteins in vivo [31,34,75]. Most notably,
K14-Cre driven inactivation of p120-catenin, the closest homolog
of p0071, leads to epidermal hyperplasia and hair loss [34] that
resemble those of FLCN inactivation. Rho signaling is known to
regulate keratinocyte differentiation and proliferation [76,77], and
may contribute to the epidermal consequences of p120-catenin
and FLCN inactivation.
In conclusion, we have uncovered a physical interaction
between FLCN and p0071 that is critical for the proper regulation
of cell-cell adhesion, RhoA activity, and epithelial cell polarity. A
mouse model of FLCN inactivation in the epidermis leads to wavy
hair and whiskers, delays in eyelid opening, hair loss, and
increased epidermal thickness, phenotypes which resemble the
inactivation of p120-catenin, the closest homolog of p0071. Taken
together, these findings reveal a novel paradigm in which loss of
the FLCN-p0071 interaction and consequent defects in cell-cell
adhesion, cell polarity and RhoA activity participates in the
pathogenesis of renal cell carcinoma, skin tumors, and cystic
airspace enlargement (Figure 7).
Materials and Methods
Yeast Two-hybrid Assay
The yeast two-hybrid assay was performed by Hybrigenics
(Paris, France). Full-length human FLCN coding sequence was
PCR amplified and inserted into pB29 vector as an N-terminal
fusion to LexA (N-FLCN-LexA-C). The construct was used as
a bait to screen the Hybrigenics Human Fetal Brain_RP1 library.
The DNA insert of the positive clones was sequenced to identify
the corresponding gene in the GenBank database.
In vitro Binding Assay
Human BHD cDNA was cloned into the pGEX4T-2 expression
vector (GE Healthcare) and transformed into BL-21 bacteria
(Stratagene). Isolation and purification of GST-FLCN or empty
GST control was performed according to a previously published
protocol [78]. Isolated recombinant proteins were immobilized on
glutathione agarose and incubated with MDCK lysates overnight.
GST-FLCN or empty GST beads were washed three times with
lysis buffer and boiled. The interacting proteins were separated by
SDS-PAGE and analyzed by immunoblot.
Cell Culture, Transfections and Plasmids
The T84, HEK293 and MDCK cell lines were purchased from
ATCC; FLCN-null UOK257 cells and FLCN re-expressing
UOK257-2 cells were a gift from Drs. Laura Schmidt and
Marston Linehan (National Cancer Institute, Bethesda, MD) [79].
All cells were maintained in DMEM supplemented with 10% FBS
and 1% pen/strep; the UOK257-2 cells were additionally
supplemented with 2 ug/mL blasticidin S (Invitrogen). Transient
DNA transfections were carried out using Fugene 6 (Roche). The
myc-FLCN expressing plasmid has been described previously [25]
and the FLAG-p0071 plasmid was a gift from Dr. Andrew
Kowalczyk at Emory University [80].
Immunoblotting
Cells were lysed on ice in urea lysis buffer (9 M urea, 1%
NP-40, 25 mM Tris pH 7.4, and 150 mM NaCl) and centri-
fuged at 14,000 rpm for 15 minutes. The supernatants were
boiled, proteins separated by SDS-PAGE, and transferred onto
PVDF membrane. Membranes were incubated with the
following antibodies: anti-FLCN, anti-zonula occludens-1, anti-
pan-keratin, and anti-keratin-18 (Cell Signaling Technology);
anti-actin, anti-JUP, and anti-tubulin (Sigma); and anti-p0071
(Progen Biotechnik, Germany); and anti-p120-catenin (Life
Technologies). Chemiluminescent signals were captured using
a Syngene G-BOX iChemi XT imager and quantified with
Syngene GeneTools software.
Hanging Drop Assay
Cell aggregates were prepared using a previously described
approach [81]. Briefly, 4000 cells suspended in a 20 uL drop were
pipetted onto the sterile cover of a culture dish. After 4 days, cell
aggregates were harvested and transferred to a tube. To shear,
Hoechst was added to each cell suspension, incubated at 37uC for
10 minutes, and pipetted 100 times in order to fragment the cell
aggregates. Bright field images were acquired using an Olympus
IX-81 microscope under 46magnification.
Cell Aggregate (Rotary Shaker) Assay
100,000 HEK293 cells were seeded on a 60 mm suspension
culture dish. Cells were incubated at 37uC on an orbital shaker at
70 rpm for 4 days, and allowed to form aggregates. Aggregate
suspensions were harvested and sheared by pipetting 15 times
using a P200 pipet. The sheared cell suspension was then
transferred to a 35 mm dish and imaged under bright field using
an Olympus IX-81 microscope. Aggregate size was quantified
using ImageJ and the Integrated Morphometry Analysis feature in
Metamorph (Sunnyvale, CA).
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T84 cells with stable knock down (FLCN, p0071 or control)
were maintained in DMEM supplemented with 10% FBS and
Puromycin (5 ug/mL). For 3D culture, approximately 4.5610
3
cells were trypsinized to a single cell suspension and re-suspended
in 500 uL medium with 2.5% Matrigel (BD Biosciences,
Heidelberg, Germany) and plated on coverglass chambers (8 well
chamber slides, Nunc) precoated with 5 uL of 100% Matrigel.
Cysts were allowed to form over 5–7 days at 37uC. For
visualization of F-actin with phalloidin Alexa 546 (Molecular
Probes, Invitrogen, Karlsruhe, Germany) the fixation and staining
procedure of Chu et al. was followed [82]. Labeled cells counter-
stained with DAPI were examined using a Zeiss LSM 700 laser
scanning confocal microscope. Images demonstrate a single
confocal section acquired at the center of the cyst.
Wound Healing Assay
Cells were plated at 75% confluency in three 35 mm dishes, and
cultured until fully confluent. Linear wounds were created by
scraping a P200 pipette tips across the surface of each confluent
monolayer. Bright field images of wound migration were acquired
at 0, 8, 24, 48 80 and 92 hours at 46magnification using an
Olympus IX-81 microscope. For each time point, the wound size
in pixels was calculated for each dish, and the average of the 3
dishes was used as a single data point.
ROCK Activity Assay
The phosphorylation of the myosin binding subunit (MBS) was
measured to analyze Rho-associated kinase (ROCK) activity using
a modification from a previously published method [35]. Briefly,
cells were harvested and fixed on ice in trichloroacetic acid (50%,
Sigma) and dithiothreitol (50 mM, Sigma) dissolved in dH2O
(freshly made before fixation). Cells were pelleted by centrifugation
at 4uC. The pellet was washed 2 times with PBS and resuspended
in extraction buffer (8 M urea, 20 mM Hepes pH8). Cell extracts
were subjected to 7% SDS-PAGE and transferred onto PVDF
membrane. Membranes were incubated with rabbit anti-phospho-
specific Thr853-MBS polyclonal antibody [83] or rabbit anti-MBS
polyclonal antibody (Covance). ROCK activity was expressed as
the ratio of phospho-MBS/total MBS.
Rho Activity Assay
Rho activity was examined using the Active Rho Pull-Down
and Detection Kit (Pierce Biotechnology) as previously described
[84]. Cells were serum-deprived for 16 h and lysed in Lysis/
Binding/Wash buffer. Lysates were incubated with a GST-fusion
protein of the Rhotekin-binding domain (RBD) and glutathione
agarose resin for 1 hour in order to pull-down Rho-GTP. The
resin was washed and Rho was extracted with 26SDS sample
buffer followed by Western blot analysis with anti-Rho antibody.
The data are presented as Rho-GTP/total Rho ratio and are
mean values 6 SE by ANOVA (Fisher test).
Generation and Analysis of Mice
All mouse experiments were carried out under guidelines
approved by the ARCH Institutional Animal Care and Use
Committee (IACUC). The ARCH IACUC specifically approved
this study. Transgenic mice with skin-specific inactivation of
mouse Bhd were generated by crossing Bhd
f/f mice (a gift from Drs.
Laura Schmidt and Marston Linehan) with Keratin14-Cre
transgenic mice (Jackson Laboratories) to establish Bhd
f/+ K14-
Cre animals. Bhd
f/+ K14-Cre mice were intercrossed to generate
Bhd
f/f K14-Cre mice. Tissue processing and staining was
Figure 7. Working Model. In wild-type cells (left) the FLCN-p0071 interaction is required for maintenance of normal epithelial cell-cell adhesion
and proper cell polarity. Red arrows indicate cell-cell adhesion forces. In FLCN-deficient cells (right), loss of the FLCN-p0071 interaction leads to
enhanced cell-cell adhesion, though we do not currently understand which cellular junctions are critical for this defect, and is accompanied by
defects in RhoA signaling and cell polarity.
doi:10.1371/journal.pone.0047842.g007
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School). Epidermal thickness was measured using Olympus
FSX100 integrated software.
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